Kennedy Lewis Investment Management to acquire the remaining stake in Rapid Micro Biosystems for $156m.

Kennedy Lewis Investment Management, an opportunistic credit manager, offered to acquire the remaining stake in Rapid Micro Biosystems, a provider of data integrity and automation technology for microbial detection in biopharmaceutical manufacturing, for $156m. "We are excited about the future business prospects of RPID and are interested in working constructively with the RPID Board of Directors with the goal of reaching agreement on a transaction that will provide all stakeholders with value, speed and certainty. We hope that the Board will work with us to maximize value and opportunities for all RPID stockholders and other stakeholders, and we look forward to receiving a response to this non-binding proposal promptly," Kennedy Lewis.